Cargando…

A novel tetramethylnaphthalene derivative synergistically inhibits HTLV-1-infected cell proliferation in combination with cepharanthine

Detalles Bibliográficos
Autores principales:	Toyama, Masaaki, Hamasaki, Takayuki, Uto, Tomofumi, Aoyama, Hiroshi, Okamoto, Mika, Hashimoto, Yuichi, Baba, Masanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112779/ http://dx.doi.org/10.1186/1742-4690-8-S1-A64

Ejemplares similares

A novel tetrahydrotetramethylbenzophenanthridinone derivative inhibits ATL cell proliferation
por: Toyama, Masaaki, et al.
Publicado: (2014)

HTLV-1 Tax peptide-carrying polyion complex nanoparticles induce potent cellular immunity in mice
por: Uto, Tomofumi, et al.
Publicado: (2014)

The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro
por: Okamoto, Mika, et al.
Publicado: (2020)

Cepharanthine in Experimental Tuberculosis
por: Sirsi, M., et al.
Publicado: (1952)

Pharmacological Activity of Cepharanthine
por: Liu, Ke, et al.
Publicado: (2023)

In vitro antiplasmodial activity of cepharanthine
por: Desgrouas, Camille, et al.
Publicado: (2014)

Reduced Tim-3 expression on HTLV-I Tax-specific cytotoxic T lymphocytes in HTLV-I infection
por: Abdelbary, Nashwa H, et al.
Publicado: (2011)

Prevalence and changing distribution of HTLV-1 and HTLV-2 infections in Spain
por: Treviño, Ana, et al.
Publicado: (2011)

Pharmacological Effects and Clinical Prospects of Cepharanthine
por: Liang, Di, et al.
Publicado: (2022)

Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors
por: Baba, Masanori, et al.
Publicado: (2017)

Histopathologic differences between human T-lymphotropic virus type 1 (HTLV-1)-positive and HTLV-1-negative polymyositis
por: Abdullah, Hazem M, et al.
Publicado: (2011)

Development of HTLV-1 Database for data management and datamining HTLV-1 sequences
por: Araujo, Thessika H A, et al.
Publicado: (2011)

HLA-A24-restricted HTLV-I-specific CTL response reduces the HTLV-I proviral load but the HLA increases the risk of HAM/TSP
por: Kubota, Ryuji, et al.
Publicado: (2011)

HTLV-1 HBZ activates mTOR signaling pathway via inhibition of GADD34
por: Mukai, Risa, et al.
Publicado: (2011)

New insights into HTLV entry
por: Pique, Claudine, et al.
Publicado: (2011)

Expression of the HBZ and tax genes of HTLV-1in infective dermatitis associated with HTLV-I (IDH)
por: Batista, Everton S, et al.
Publicado: (2011)

Analysis of temporal expression of HTLV-2 reveals similarities and functional differences from HTLV-1
por: Bender, Cecilia, et al.
Publicado: (2011)

HTLV-1 infection and associated diseases in Peruvian twins probably exposed to HTLV-1 mother-to-child transmission
por: Alvarez, Carolina, et al.
Publicado: (2011)

Cellular tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2)
por: Kannian, Priya, et al.
Publicado: (2011)

HTLV-3 and HTLV-4 antisense proteins activate JunB-, c-Jun- and JunD-dependent transcription
por: Larocque, Émilie, et al.
Publicado: (2011)

In vitro and in vivo combination of cepharanthine with anti-malarial drugs
por: Desgrouas, Camille, et al.
Publicado: (2014)

Cepharanthine inhibits dengue virus production and cytokine secretion
por: Phumesin, Patta, et al.
Publicado: (2022)

The reverse genetics of HTLV-1 infected patients
por: Alcantara, Luiz C, et al.
Publicado: (2011)

17beta-estradiol (E2) abrogated osteolysis induced by HTLV-1 Env protein in vivo
por: Sagara, Yasuko, et al.
Publicado: (2011)

Mother-to-child transmission of HTLV-1:in vitro study of HTLV-1 passage across a tight human epithelial barrier
por: Martin-Latil, Sandra, et al.
Publicado: (2011)

SELECTIVE INHIBITION OF HEPATITIS C VIRUS REPLICATION BY ALPHA-ZAM, A NIGELLA SATIVA SEED FORMULATION
por: Oyero, Olufunmilayo G., et al.
Publicado: (2016)

The plasticity of HTLV-1 infected CD4+CD25+CCR4+ T-cells through HTLV-1 tax in HAM/TSP
por: Araya, Natsumi, et al.
Publicado: (2011)

The clinical utility of HTLV-1 viral load measurement
por: Demontis, Maria A, et al.
Publicado: (2011)

Arsenic trioxyde in the treatment of HTLV1 associated ATLL
por: Suarez, Felipe, et al.
Publicado: (2011)

Quality of life (QOL) and depression in HTLV-1 carriers
por: Galvão-Phileto, Ana V, et al.
Publicado: (2011)

Expression and purification of the HTLV-1 transforming protein Tax
por: Evans, Whitney, et al.
Publicado: (2011)

MicroRNA expression in HTLV-1 infection and pathogenesis
por: D'Agostino, Donna M, et al.
Publicado: (2011)

Kinetics and intracellular compartmentalization of HTLV-1 gene expression
por: Rende, Francesca, et al.
Publicado: (2011)

Prevalence of XMRV in blood donors, HTLV and HIV cohorts
por: Qiu, Xiaoxing, et al.
Publicado: (2011)

Cepharanthine inhibits hepatocellular carcinoma cell growth and proliferation by regulating amino acid metabolism and suppresses tumorigenesis in vivo
por: Feng, Fan, et al.
Publicado: (2021)

Cepharanthine and Curcumin inhibited mitochondrial apoptosis induced by PCV2
por: Xu, Yinlan, et al.
Publicado: (2020)

Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury
por: Liang, Di, et al.
Publicado: (2023)

Prevalence of HTLV-1/2 and HIV-1/2 in individuals attending Public Health Center in Mozambique. One HTLV-1 symptomatic case report
por: Caterino-de-Araujo, Adele, et al.
Publicado: (2011)

HTLV-1 Tax Specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications
por: Leal, Fabio E, et al.
Publicado: (2011)

Neural bystander damage by infiltrating virus-infected T cells and the cytotoxic T lymphocytes in HTLV-I-associated neurological disease
por: Matsuura, Eiji, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_msvqcla0pdj5dq9hh8agnk6mub